Hematology & Oncology
Immunotherapy Enhances Outcomes for University of Minnesota Health Patients with Hematologic Malignancies
Patients with relapsed and refractory leukemia and lymphoma currently have few curative options. Through a combination of leading-edge scientific research, clinical trials and advanced patient care, cancer specialists at the University of Minnesota Health Cancer Care are transforming management strategies for refractory disease.
Children’s Minnesota Names Marc Gorelick, MD, as Next President and Chief Operating Officer
Children’s Minnesota is pleased to welcome Marc Gorelick, MD, as its new President and Chief Operating Officer. Dr. Gorelick, who is Chief Operating Officer and Executive Vice President of Children’s...